BOSTON--(BUSINESS WIRE)--From improving drug safety to diagnosing rare diseases to visualizing cancer genomics datasets, the future of precision medicine is being shaped by “data-driven” technologies and innovations such as AI, deep learning and data science. Indeed, the ability to harness, share, visualize, analyze and act on data is opening new frontiers in drug discovery and development, biomedical research and clinical and healthcare initiatives.
Today, Cambridge Healthtech Institute announced highlights of the annual Bio-IT World Conference & Expo—where more than 3,400 life sciences, pharmaceutical, clinical, healthcare and IT professionals from more than 40 countries will explore these advances together. Now in its 18th year, Bio-IT World 2019 is the premier event focused on the IT and informatics applications and enabling technologies that are pushing precision medicine ahead. The event will take place April 16-18 at the Seaport World Trade Center in Boston and will feature several distinguished plenary keynoters:
- John Wilbanks, Chief Commons Officer, Sage Bionetworks will discuss Open Science: From Ideology to Methodology
- Panelists looking at AI in Practice: How New Technologies are Changing Bio-IT will include Anne E. Carpenter, Ph.D., Senior Director of the Imaging Platform, Institute Scientist, Broad Institute of Harvard and MIT; Iya Khalil, Ph.D., Chief Commercial Officer and Co-founder, GNS Healthcare; Mariana Nacht, Ph.D., Chief Scientific Officer, Vivid Biosciences; and Susie Stephens, Ph.D., Senior Director, Oncology & Vaccine R&D Information Technology, Pfizer.
- Vijay K. Bulusu, Head, Data & Digital Innovation, Pfizer, will keynote the concluding day of sessions.
“The Bio-IT World Conference & Expo has both depth and breadth of insights. Here, our community can dig deep, applying the latest research and new products to propel their work forward, or use the event to gain a wide understanding of trends and areas of opportunity, sparking new ideas and collaborations. There are exciting technologies maturing in the bio-IT space, and there’s no better place to really develop your understanding of what’s available, what’s possible, and where to go next,” said Allison Proffitt, Editorial Director, Bio-IT World, who will moderate the plenary AI panel.
Bio-IT World 2019 will feature more than 280 educational sessions in 17 tracks, including three separate AI tracks focused on Pharma & Biotech, Genomics and Healthcare. It will also feature in-depth pre-conference workshops; 1-on-1 Networking; a FAIR Data Hackathon; awards for innovation (practices and technologies) and open access; and an Exhibit Hall with more than 185 leading companies and startups.
About Cambridge Healthtech Institute
Cambridge Healthtech Institute (CHI), a division of Cambridge Innovation Institute, is the preeminent life science network for leading researchers and business experts from top pharmaceutical, biotech, CROs, academia, and niche service providers. CHI is renowned for its vast conference portfolio held worldwide including PepTalk, Molecular Medicine Tri-Conference, SCOPE Summit, Bio-IT World Conference & Expo, PEGS Summit, Drug Discovery Chemistry, Biomarker World Congress, World Preclinical Congress, The Bioprocessing Summit, Next Generation Dx Summit, Immuno-Oncology Summit, and Discovery on Target. CHI's portfolio of products include Cambridge Healthtech Institute Conferences, Barnett International, Insight Pharma Reports, Bio-IT World, Clinical Informatics News, and Diagnostics World.